Уровень проадреномедуллина и клинические особенности течения коронавирусной инфекции, вызванной SARS-CoV-2: проспективное клиническое исследование
- Авторы: Астаповский А.А1, Дроздов В.Н1, Ших Е.В1, Лазарева Н.Б1, Мелконян Г.Г2, Мещеряков А.А2, Цепкова Е.В3
-
Учреждения:
- Первый МГМУ им. И.М. Сеченова (Сеченовский Университет)
- Госпиталь для ветеранов войн № 3 ДЗМ
- Городская клиническая больница № 40 ДЗМ
- Выпуск: Том 29, № 5 (2022)
- Страницы: 26-31
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/320996
- DOI: https://doi.org/10.18565/pharmateca.2022.5.26-31
- ID: 320996
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Ключевые слова
Полный текст
Об авторах
А. А Астаповский
Первый МГМУ им. И.М. Сеченова (Сеченовский Университет)
Email: ai.astapovskii@gmail.com
аспирант кафедры клинической фармакологии и пропедевтики внутренних болезней ИКМ им. Н.В. Склифосовского Москва, Россия
В. Н Дроздов
Первый МГМУ им. И.М. Сеченова (Сеченовский Университет)Москва, Россия
Е. В Ших
Первый МГМУ им. И.М. Сеченова (Сеченовский Университет)Москва, Россия
Н. Б Лазарева
Первый МГМУ им. И.М. Сеченова (Сеченовский Университет)Москва, Россия
Г. Г Мелконян
Госпиталь для ветеранов войн № 3 ДЗММосква, Россия
А. А Мещеряков
Госпиталь для ветеранов войн № 3 ДЗММосква, Россия
Е. В Цепкова
Городская клиническая больница № 40 ДЗММосква, Россия
Список литературы
- Zhu N., Zhang D., Wang W., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N EngiJ Med 2020;382(8):727-33. doi: 10.1056/nejmoa2001017.
- Poston J., Patel B., Davis A. Management of Critically III Adults With COVID-19. JAMA. 2020;323(18):1839-41. doi: 10.1001/jama.2020.4914.
- Varga Z., Flammer A., Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-18. Doi: 10.1016/ s0140-6736(20)30937-5.
- Wilson D., Schefold J., Baldir J., et al. Adrenomedullin in COVID-19 induced endotheliitis. Critical Care. 2020; 24(1):411. doi: 10.1186/s13054-020-03151-7.
- Imai Y, Kuba K., Rao S., et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112-16. doi: 10.1038/nature03712.
- Vieceli Dalla Sega F, Fortini F, Spadaro S., et al. Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study Clin Transplat Med. 2021;11(3):e283. Doi: 10.1002/ ctm2.283.
- Na gele M., Haubner B., Tanner F, et al. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atheroscler. 2020;314:58-62. Doi: 10.1016/j. atherQselerosis.o02Q.10.014.
- Qiu P, Zhou Y, Wang F, et al. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clin Exp Res. 2020;32(9):1869-78. Doi: 10.1007/ s40520-020-01664-3.
- Wu Z, McGoogan J. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA. 2020;323(13):1239. Doi: 10.1001/ jrmr.2020.2648.
- Schdnauer R., Els-Heindl S., Bssk-Siskingsr A. Adrenomedullin - new perspectives of a potent peptide hormone. J Pept Sci. 4917;43(7-8):474-85. doi: 10.1002/psc2953.
- Nakamura M, Yoshida H., Makita S., et al. Potent and Long-Lasting Vasodilatory Effects of Adrsnomsdullin in Humans. Circulat. 1997;95(5):1214-21. doi: 10.1161/01.cir.95.5.1214.
- Voors A, Kremer D., Geven C., et al. Adrsnomsdullin in heart failure: pathophysiology and therapeutic application. Eur. J. Heart Failure. 4918;41(4):163-71. Doi: 10.1002.1366.
- Tsmms2fsld-Wollbrйsk B., Brell B., David I., et al. Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock.Intens Care Med. 2007;33(4):703-10. Doi: 10.1007/ s00134-007-0561-y.
- Pereira J., Azevedo A., Bas'lio C., et al. Mid-regional proadrenomedullin: An early marker of response in critically ill patients with severe community-acquired pneumonia? Revista Portug Pneumol. (English Edition). ~016;(6):308-1. Doi: 10.1016/j. rppnen.2016.03.012.
- Spoto S., Fogolari M., De Florio L., et al. Prosaisitonin and MR-proAdrenomedullin combination in the etiological diagnosis and prognosis of sepsis and septic shock. Microb Pathogen. 2019;137:103763. doi: 10.1016/j.misprtS.2019.103763.
- Hirayama N., Kitamura K., Imamura T, et al. Secretion and clearance of the mature form of adrenomedullin in humans. Life Sci. 1999;64(26):2505-509. doi: 10.1016/s0024-3205(99)00208-8.
- Morgena N., Struck J., Alonso C., Bergmann A. Measurement of Midregional Proadrenomedullin in Plasma with an Immunoluminomstris Assay. Clin. Chemistry. 2005;51(10):1823-29. Doi: 10.1373/ siinsSsm.2005.051110.
- Saeed K., Wilson D., Bloos F, et al. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study. Critical Care. 2019;23(1):255. doi: 10.1186/s13054-019-2329-5.
- Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)», версия 11 от 07.05.2021) [Электронный ресурс]. [Interim guidelines «Prevention, diagnosis and treatment of a new coronavirus infection (COVID-19)», version 11 of 05/07/2021). (In Russ.)]. URL: http2://xn--80as2fpsbagmfbls0a.xn-p1ri/ri/dos/872/rttrsS/Bmr_COVID-19_compressed.pdf
- National Early Warning Score (NEWS): Standardising the assessment of acuteillness severity in the NHS. Report of a working party. Royal College of Physicians. London: RCP.
- Asksemrnn M., Vsrisdsn S., Kuehnel M., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogsnssis in Covid-19. N Engl J Med. 2020;383(2):120-28. Doi: 10.1056/ NEJMor2015432.
- Zhou Y, Yang Q., Chi J., et al.Comorbidities and the risk of severe or fatal outcomes associated with coron'irus disease 2019: A systematic review and meta-analysis.Int. J. Infect. Dis. Q0Q0;99:47-56. doi: 10.1016/j.ijid.2020.07.029.
- Bermejo-Martin J., Almansa R., Torres A., et al. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction. Card'oYasc Res. 2020;116(10):e132-33. doi: 10.1093/cvr/ svrr140.
- Evans P, Rainger G., Mason J., et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardbsc Res. 2020;116(14):2177-84. doi: 10.1093/svr/svaa230.
- Goshua G.,Pins A.,Msiziis S M.,etal. Endot SsiiopatSy in COVD-W-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. Q0Q0;7(8):s575-8Q. Doi: 10.1016/ s2352-3026(20)30216-7.
- Oner O., Deveci F, Telo S., MR-proADM and MR-proANP levels in patients with acute pulmonary embolism. J Med Biochem. Q0Q0;39(3):3Q8-335. doi: 10.2478/jomb-2019-0049.
- Hoeiushi Y, Wsttsrstsn N., Maisel A. Response by Horiuchi et al. to Letter Regarding Article, "Biamrrksrs Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction". Circulation. 2021;143(8):s252-s253. Doi: 10.1161/ .120.051634.
- Huang D., Angus D., Kellum J., et al. Midregional Proadrenomedullin as a Prognostic Tool in Community-Acquired Pneumonia. Chest. 2009;136(3):823-31. doi: 19.1378/sSest.98-1981.
- Bernal-Morell E., Garcfa-Villalba E., Vera M., et al. Usefulness of m'dregimpro-rdrsnomsduiiin as a marker of organ damage and predictor of mortality in patients with sepsis. J Infect. 2018;76(3):249-57. doi: 10.1016/j.jinf.2017.12.003.
- Valenzuela Sanchez F, Valenzuela Mendez B., Rodriguez Gutierrez J., et al. Initial levels of mr-prordrsnomsduiiin: a predictor of severity in patients with influenza a virus pneumonia.Intens. Care Med Experim. 2015;3(Suppl. 1). doi: 10.1186/2197-425x-3-s1-r832.
- Julian-JimSnez A., Garcia D.E., Gonzalez Del Castillo J., et al. Key issues in emergency department management of COVID-19: proposals for improving care for patients in Latin America. Emergences. 2021;33:42-58.
- Viaggi B., Poole D., Tujjar O., et al. Mid regional pro-rdrsnomsduiiin for the prediction of organ failure in infection. Results from a single centre study. PLOS ONE. 2018;13(8):e0201491. Doi: 10.1371/ journal.pone.o201491.